- Nachrichtendetail
-
01.04.2024 14:15:09 - dpa-AFX: *VERTEX ADVANCES INAXAPLIN INTO PHASE 3 PORTION OF PHASE 2/3 TRIAL FOR TREATMENT OF APOL1-MEDIATED KIDNEY DISEASE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
VERTEX PHARMAC. DL-,01 | 882807 | Xetra | 412,300 | 29.05.24 15:51:53 | -3,250 | -0,78% | 410,000 | 411,850 | 413,250 | 415,550 |
